Topical Steroid Withdrawal (TSW): What It Is, How It Happens, and What to Expect

Topical steroid withdrawal happens when skin that has been relying on topical corticosteroids for an extended period reacts to their absence with a rebound inflammatory response. Redness, burning, intense itching — often more severe than whatever the steroids were originally treating. The medicine does its job. Then stopping it creates a new problem. (Your skin, it turns out, has strong opinions about changes to its routine.)

TSW develops when the skin builds a biological dependency on external corticosteroids, gradually altering how it regulates its own inflammation. When the steroids stop, that regulatory system is temporarily out of balance — and the skin makes its objections known loudly and at length.

This article covers how TSW happens at the biological level, who it most commonly affects, what the symptoms look like, and what the evidence actually says about recovery.

What is topical steroid withdrawal?

Topical steroid withdrawal is a rebound reaction that occurs after stopping topical corticosteroids — the steroid-based creams and ointments prescribed for eczema, psoriasis, dermatitis, and other inflammatory skin conditions.

The short version: topical steroids work by suppressing the skin's inflammatory response. Used as directed and for the right duration, that suppression is exactly what they're meant to do. The problem arises when skin is exposed to them repeatedly over months or years — at which point the skin's own inflammatory regulation begins to adapt to the presence of external steroids. When the steroids stop, that adapted system overcorrects.

The condition goes by several names: topical steroid withdrawal (TSW), topical steroid addiction (TSA), and Red Skin Syndrome (RSS). Different names, same underlying mechanism. The medical community debated terminology for decades while patients worked through the condition without a formal diagnosis to point to. (The medical establishment officially agreed on what patients had been describing since the 1970s — progress, as they say, takes its time.)

The condition is distinct from a standard eczema flare. It is driven by the biology of steroid discontinuation, not by the original skin condition itself. This distinction matters for how it is managed.

How TSW actually happens — the mechanism

Several mechanisms contribute to TSW. They don't all act independently — they compound each other. Understanding each one makes the overall picture clearer.

Tachyphylaxis: the diminishing return

When topical steroids are applied repeatedly to the same area, skin develops a reduced response to the same dose over time. The clinical effect weakens. More product gets applied to achieve the same result. This is tachyphylaxis — a rapid decrease in response following repeated doses — and it begins relatively early with continuous steroid use. It's the first signal that a dependency is forming.

Suppressed cortisol production

Topical corticosteroids deliver synthetic cortisol directly to the skin. Over time, the skin's keratinocytes — the cells that make up most of the outer skin layer — reduce their own cortisol production in response. The body doesn't run two parallel systems when one is being externally supplied.

When external steroids stop, keratinocytes need time to restart their own production. During that interval, the anti-inflammatory coverage that was there is gone, and the backup isn't ready. That gap is where TSW symptoms emerge.

Rebound vasodilation

Topical steroids constrict blood vessels in the skin — one of the mechanisms behind the redness-reducing effect. When steroids stop, the opposite happens: blood vessels widen, driven by increased nitric oxide release. The blood vessels, having been constricted for months or years, overcorrect substantially in the other direction. This vasodilation produces the characteristic redness and warmth that marks early TSW — skin that looks flushed, hot to the touch, and inflamed in ways that go beyond the original condition.

Cytokine cascade

The anti-inflammatory suppression from topical steroids was also keeping a certain amount of cytokine activity in check. When that suppression lifts, inflammatory signals release in a burst — a rebound cytokine cascade. This is the inflammatory response that the steroids had been suppressing, releasing in a compressed wave rather than in the smaller amounts it would have represented over a longer period.

Symptoms of TSW

The symptom picture of TSW differs enough from typical eczema that it can be recognized — though distinguishing the two isn't always straightforward without clinical experience.

Burning more than itching

While itch is a defining feature of eczema, TSW tends to present with a pronounced burning sensation — often described as skin on fire rather than an urge to scratch. This burning quality is one of the distinguishing markers. It's a different subjective experience, and patients who've had both consistently describe it as worse.

Redness that spreads beyond original application areas

The redness associated with TSW can spread significantly beyond the areas where steroids were applied. In more severe cases, the "red sleeve" pattern has been documented — diffuse redness across the limbs, face, and torso. This spreading redness is a notable TSW marker and helps distinguish it from a localized eczema flare.

Shedding, oozing, and skin changes

Skin in TSW may shed heavily (desquamation) and produce clear or serous fluid, particularly in the early stages of withdrawal. Edema — swelling from fluid retention in the tissue — is also documented. These presentations are not typical of most eczema flares and contribute to TSW's distinct clinical picture.

Systemic symptoms

TSW isn't always only a skin condition. Systemic effects can include difficulty regulating body temperature, night sweats, and significant sleep disruption — driven partly by the intensity of the itch and burning, and partly by the broader physiological response to steroid discontinuation. These systemic effects tend to be most pronounced in the early weeks.

How TSW differs from an eczema flare

The burning-over-itching quality, the redness spreading beyond original steroid application sites, the timing (symptoms beginning within days to weeks of stopping steroid use), and the presence of shedding and oozing collectively suggest TSW rather than a regular flare. That said, the two conditions can overlap, particularly in people with pre-existing atopic dermatitis. Working through the differential with a dermatologist familiar with TSW is worth doing before drawing conclusions.

Who is most at risk?

Not everyone who uses topical steroids will experience TSW. The risk factors that appear consistently across the research come down to potency, duration, location, and individual skin history.

Potency. High-potency steroids (Class 1–3) carry substantially more risk than low-potency options. Class 1 steroids like clobetasol propionate are roughly 600 times more potent than over-the-counter hydrocortisone. The more potent the steroid, the more significant the effect on the skin's regulatory systems — and the higher the discontinuation risk.

Duration and frequency. Most cases develop after months to years of daily use. Six or more months of daily application on the face, or twelve or more months on the body, represents the general threshold documented in published literature. TSW cases have been reported after as little as two weeks of use in rare instances — but these appear to be genuine outliers rather than the norm.

Location on the body. The face and genitals are high-risk areas. Skin in these regions is thinner and more permeable, leading to greater systemic absorption of the active ingredient. Facial TSW tends to produce more severe presentations than body-site TSW.

Prior atopic history. People with atopic dermatitis (eczema) appear more vulnerable — which is notable, given that eczema is one of the primary conditions topical steroids are prescribed to treat. A person using topical steroids for eczema is, by definition, someone who already has the underlying condition most associated with TSW risk.

Is TSW a real condition?

Yes — though the path to that consensus has been slower than most patients would consider acceptable.

TSW was first described in the medical literature in the 1970s. It remained on the fringes of dermatological recognition for decades, partly because the condition has no definitive diagnostic test, and partly because the manufacturers of topical steroids had limited incentive to amplify awareness of a withdrawal complication.

The shift toward formal recognition came largely through patient communities. After 2013, when the International Topical Steroid Addiction Network (ITSAN) began systematically organizing and documenting cases, peer-reviewed literature began accumulating at a more significant pace. The National Eczema Association formally recognized TSW in 2021. The American Academy of Dermatology has acknowledged the condition and published guidance for clinicians on recognition and management.

The question "is TSW real?" still carries weight in some clinical settings because the condition lacks a standardized ICD-10 billing code in several jurisdictions — which affects how readily physicians document and acknowledge it. That's an administrative gap, not a scientific one. The research supporting TSW as a physiologically distinct condition is now substantial.

How long does TSW last?

The honest answer: it varies, and the range is wide enough to be genuinely frustrating.

Published research suggests that approximately 77% of TSW cases resolve within three months. For the remaining cases, recovery can take significantly longer — rare documented cases extend to five years. Duration appears to correlate with the potency and duration of prior steroid use, though individual variation is substantial and not fully predictable.

Recovery doesn't tend to be linear — which is a clinical way of saying it moves sideways and backward before it moves forward. Many people experience cycles of improvement followed by setback, with "waves" of flaring that can make it difficult to judge progress. This non-linear course is one of the things that makes TSW particularly exhausting to manage emotionally; the timeline is genuinely uncertain.

There is currently no proven treatment that accelerates TSW recovery. The evidence for dupilumab (a biologic medication used for moderate-to-severe atopic dermatitis) in TSW cases is preliminary and not yet conclusive. Oral corticosteroids are not recommended for TSW management — and given the mechanism, that's not surprising.

Gradual tapering of topical steroids, rather than abrupt discontinuation, is generally preferred where it is medically feasible. This is a conversation to have with a dermatologist, not a decision to make unilaterally.

Supporting your skin during TSW recovery

Clinical articles cover the mechanism well. What gets less attention is the day-to-day reality of managing highly reactive, inflamed skin during a recovery process with an uncertain timeline. A few things appear consistently across clinical guidance and patient experience:

Fragrance-free everything. Skin in TSW is hyperreactive. Products marketed as "sensitive skin" frequently still contain fragrance, preservatives, or active ingredients that aggravate inflamed skin. Short ingredient list, no fragrance, no alcohol, no essential oils. Check every product.

Barrier support. Thick, fragrance-free emollients — simple petroleum-based products or ceramide-rich creams — help maintain barrier function during recovery. Apply after any water exposure.

Avoid temperature extremes. Hot showers and baths can aggravate TSW-related vasodilation and increase itch intensity. Lukewarm or cool water is more comfortable during active phases.

The soak and seal approach. Apply fragrance-free emollient within a few minutes of getting out of water, while skin is still slightly damp. The approach reduces transepidermal water loss and is one of the consistently recommended interventions for atopic skin in flare.

For families navigating TSW recovery, finding genuinely fragrance-free, non-toxic skin support options takes more searching than it should. We built GentleSen HOCl tablets for exactly this context — our son went through TSW and severe eczema in 2024, and most products marketed as "gentle" weren't, once we read the ingredient list.

See GentleSen HOCl Tablets →

Straight answers

What is topical steroid withdrawal?

Topical steroid withdrawal (TSW) is a rebound inflammatory reaction that occurs after stopping topical corticosteroids following prolonged use. The skin, which has adapted to the presence of external steroids and reduced its own inflammatory regulation accordingly, overcorrects when those steroids stop. The result is redness, burning, intense itch, and skin changes that typically exceed the original condition being treated.

How long does it take for TSW to develop?

Most cases of TSW develop after months to years of daily steroid use. The general threshold cited in published literature is six or more months of daily use on the face, or twelve or more months on the body, using moderate-to-high potency formulations. Rare cases have been reported after as little as two weeks, though these are outliers. The higher the potency and the more sensitive the application site, the shorter the period required to develop dependency.

What does TSW feel like — and how is it different from an eczema flare?

The most consistent differentiating feature is burning rather than itch as the dominant sensation — TSW is frequently described as "skin on fire" rather than the urge to scratch associated with eczema. Redness that spreads beyond original steroid application areas, shedding, oozing, and systemic symptoms like temperature dysregulation also suggest TSW rather than a standard flare. Timing is another clue: TSW symptoms begin within days to weeks of stopping steroid use.

How long does TSW last?

Approximately 77% of cases resolve within three months, according to published research. The remaining cases can take substantially longer — rare documented cases extend to five years. Duration appears to correlate with the potency and duration of prior steroid use, though individual variation is significant. Recovery is typically non-linear, with cycles of improvement and setback rather than steady progression.

Does TSW go away on its own?

For most people, yes — the skin's regulatory systems recalibrate over time without ongoing intervention. There is currently no proven treatment that accelerates recovery. Supportive skincare (fragrance-free products, barrier emollients, temperature management) can make the process more manageable, but it does not shorten the underlying timeline. Severity varies significantly, and medical supervision is recommended throughout, particularly in the early stages.

Is topical steroid withdrawal rare?

TSW is rare when topical steroids are used exactly as directed — short courses, appropriate potency for the condition, with breaks between treatment periods. Risk increases significantly with high-potency steroids applied daily to the face or sensitive areas over many months. Given how commonly topical steroids are prescribed for long-running conditions like eczema, the number of people at elevated TSW risk is not negligible. Exact prevalence data is not well-established, partly because TSW lacks a standardized diagnostic code in many countries.

Can you use topical steroids safely without risking TSW?

Yes. Topical corticosteroids have a well-established therapeutic role when used appropriately — correct potency for the condition and body area, treatment duration as directed, with breaks rather than continuous daily application. TSW is specifically associated with prolonged misuse: high-potency steroids applied daily without breaks, often to the face, over many months or years. Using a low-potency steroid intermittently for an acute eczema flare, as directed, is not the same situation as the pattern that leads to TSW.